NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Hematology Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hematology Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Thrombocytopenic Purpura



Data from University of Oklahoma advance knowledge in thrombocytopenic purpura



July 20th, 2009

"with apparent complete recovery from thrombotic thrombocytopenic purpura (TTP) often complain of problems with memory, concentration, and fatigue. Twenty-four patients who were enrolled in the Oklahoma TTP-HUS Registry for their initial episode of TTP, 1995-2006, and who had ADAMTS13 activity of less than 10 percent were evaluated for a broad range of cognitive functions 0.1 to 10.6 years (median, 4.0 years) after their most recent episode," scientists writing in the journal Transfusion report.

"At the time of their evaluation, they had normal physical and Mini-Mental State Examinations and no evidence of TTP. The patients, as a group, performed significantly...


Source: Hematology Week (2009-07-20)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login